Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Current Medicinal Chemistry
|
June 25, 2009
Receptor dependent multidimensional QSAR for modeling drug--receptor interactions
Jaroslaw Polanski
Expert Opinion on Drug Discovery
|
March 19, 2013
Drug design using comparative molecular surface analysis
Jaroslaw Polanski
Advanced Drug Delivery Reviews
|
September 5, 2003
Self-organizing neural networks for pharmacophore mapping
Jaroslaw Polanski
International Journal of Molecular Sciences
|
March 10, 2022
Unsupervised Learning in Drug Design from Self-Organization to Deep Chemistry
Jaroslaw Polanski
Journal of Chemical Information and Computer Sciences
|
November 25, 2003
Modeling steric and electronic effects in 3D- and 4D-QSAR schemes: predicting benzoic pK(a) values and steroid CBG binding affinities
Jaroslaw Polanski, Andrzej Bak
Future Medicinal Chemistry
|
July 16, 2019
Ligand potency - an essential estimator for drug design: between intuition, misinterpretation and serendipity
Jaroslaw Polanski, Andrzej Bak
Molecular Diversity
|
February 11, 2004
Comparative molecular surface analysis: a novel tool for drug design and molecular diversity studies
Jaroslaw Polanski, Rafal Gieleciak
Journal of Chemical Information and Modeling
|
May 11, 2017
Between Descriptors and Properties: Understanding the Ligand Efficiency Trends for G Protein-Coupled Receptor and Kinase Structure-Activity Data Sets
Jaroslaw Polanski, Aleksandra Tkocz
Bioorganic & Medicinal Chemistry
|
September 28, 2005
A 4D-QSAR study on anti-HIV HEPT analogues
Andrzej Bak, Jaroslaw Polanski
Journal of Chemical Information and Modeling
|
March 27, 2007
Modeling robust QSAR. 2. iterative variable elimination schemes for CoMSA: application for modeling benzoic acid pKa values
Rafal Gieleciak, Jaroslaw Polanski
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Current Medicinal Chemistry
|
June 25, 2009
Receptor dependent multidimensional QSAR for modeling drug--receptor interactions
Jaroslaw Polanski
Expert Opinion on Drug Discovery
|
March 19, 2013
Drug design using comparative molecular surface analysis
Jaroslaw Polanski
Advanced Drug Delivery Reviews
|
September 5, 2003
Self-organizing neural networks for pharmacophore mapping
Jaroslaw Polanski
International Journal of Molecular Sciences
|
March 10, 2022
Unsupervised Learning in Drug Design from Self-Organization to Deep Chemistry
Jaroslaw Polanski
Journal of Chemical Information and Computer Sciences
|
November 25, 2003
Modeling steric and electronic effects in 3D- and 4D-QSAR schemes: predicting benzoic pK(a) values and steroid CBG binding affinities
Jaroslaw Polanski, Andrzej Bak
Future Medicinal Chemistry
|
July 16, 2019
Ligand potency - an essential estimator for drug design: between intuition, misinterpretation and serendipity
Jaroslaw Polanski, Andrzej Bak
Molecular Diversity
|
February 11, 2004
Comparative molecular surface analysis: a novel tool for drug design and molecular diversity studies
Jaroslaw Polanski, Rafal Gieleciak
Journal of Chemical Information and Modeling
|
May 11, 2017
Between Descriptors and Properties: Understanding the Ligand Efficiency Trends for G Protein-Coupled Receptor and Kinase Structure-Activity Data Sets
Jaroslaw Polanski, Aleksandra Tkocz
Bioorganic & Medicinal Chemistry
|
September 28, 2005
A 4D-QSAR study on anti-HIV HEPT analogues
Andrzej Bak, Jaroslaw Polanski
Journal of Chemical Information and Modeling
|
March 27, 2007
Modeling robust QSAR. 2. iterative variable elimination schemes for CoMSA: application for modeling benzoic acid pKa values
Rafal Gieleciak, Jaroslaw Polanski
Page
of 7